News Feed

Wednesday, February 20, 2019

By Will Boggs MD

NEW YORK (Reuters Health) - The new recombinant zoster vaccine (RZV) is more cost-effective than both the zoster vaccine live (ZVL) and no vaccination for preventing herpes zoster and related complications, according to a model study.

Wednesday, February 6, 2019

By Lisa Rapaport

Monday, February 4, 2019

By Reuters Staff

NEW YORK (Reuters Health) - Exogenous testosterone increases the risk of acne on the chest and abdomen in transgender men, new research shows.

Thursday, January 17, 2019

By Will Boggs MD

Wednesday, January 16, 2019

By Marilynn Larkin

NEW YORK (Reuters Health) - Close to 44% of U.S. physicians are burned out, and 15% are depressed and thinking about suicide, according to a survey conducted by Medscape.

Tuesday, January 15, 2019

By Reuters Staff

NEW YORK (Reuters Health) - Late-life expectancy (LLE) is a better measure of survival benefit with immune-checkpoint inhibitors than is the American Society of Clinical Oncology Value Framework (ASCO-VF), according to a new report.

Monday, January 14, 2019

By Will Boggs MD

NEW YORK (Reuters Health) - The 2019 edition of the American College of Physicians (ACP) ethics manual provides a 6-step approach to resolving ethical dilemmas and adds or expands sections that address emerging issues in 21st century medicine.

Monday, January 7, 2019

By Will Boggs MD

NEW YORK (Reuters Health) - Transplanting a combination of noncultured dermal cell suspension (NCDS) and epidermal cell suspension (NCES) provides better responses in patients with vitiligo, compared with NCES transplantation alone, researchers from India report.